Syra Health Corp. Class A Common Stock
SYRA
SYRA was delisted on the 17th of April, 2025.
6 hedge funds and large institutions have $69.1K invested in Syra Health Corp. Class A Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
100% more funds holding
Funds holding: 3 → 6 (+3)
77% less capital invested
Capital invested by funds: $294K → $69.1K (-$225K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.82K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$19 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3 |
| 4 |
JP Morgan Chase
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$63.9K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Walleye Capital
New York
| $56K | -$63.9K | -41,435 | -43% |
|
|
TC
2
Torno Capital
Cohasset,
Massachusetts
| $11.2K | +$17K | +11,000 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1.86K | +$2.82K | +1,829 | New |
|
|
4
Wells Fargo
San Francisco,
California
| $12 | +$19 | +12 | New |
|
|
5
Bank of America
Charlotte,
North Carolina
| $2 | +$3 | +2 | New |
|
|
6
JP Morgan Chase
New York
| $2 | +$3 | +2 | New |
|
|
FIA
7
FNY Investment Advisers
New York
| – | -$4K | -1,500 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$1.19K | -396 | Closed |
|
SYRA Hedge Fund Activity: Q4 2023 in Review
6 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Syra Health Corp. Class A Common Stock (SYRA) for Q4 2023, worth a combined $69.1K — down 77% from $294K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SYRA positions and 2 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $2.82K. The largest seller was Walleye Capital, cutting an estimated $63.9K.
- 6 institutional investors held Syra Health Corp. Class A Common Stock (SYRA) as of Q4 2023, up from 3 in Q3 2023.
- Funds reported $69.1K of Syra Health Corp. Class A Common Stock stock for Q4 2023, down 77% quarter-over-quarter.
- 5 funds opened new Syra Health Corp. Class A Common Stock positions in Q4 2023 and 2 closed out, a net change of +3 holders.
- The largest Syra Health Corp. Class A Common Stock buyer in Q4 2023 was Tower Research Capital (TRC), an estimated $2.82K added.
- The largest Syra Health Corp. Class A Common Stock seller in Q4 2023 was Walleye Capital, an estimated $63.9K sold.
Based on aggregated 13F filings for Q4 2023.